Royal Bank Of Canada Dexcom Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Dexcom Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 1,011,157 shares of DXCM stock, worth $80.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,011,157

Previous 1,224,677 17.43%

Holding current value

$80.9 Million

Previous $139 Million 51.2%

% of portfolio

0.01%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $13.7 Million - $24.8 Million	-213,520 Reduced 17.43%	1,011,157 $67.8 Million
Q2 2024 Nov 06, 2024	SELL	$110.31 - $140.45 $440,026 - $560,255	-3,989 Reduced 0.32%	1,224,677 $139 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $27.3 Million - $34.8 Million	247,818 Added 25.27%	1,228,666 $139 Million
Q1 2024 Nov 05, 2024	SELL	$114.22 - $140.1 $28.8 Million - $35.3 Million	-252,045 Reduced 20.51%	976,621 $135 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $39.9 Million - $48.9 Million	-349,257 Reduced 26.26%	980,848 $136 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $25.4 Million - $41.8 Million	336,896 Added 33.92%	1,330,105 $165 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $50.9 Million - $81.6 Million	-591,495 Reduced 37.33%	993,209 $92.7 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $96.5 Million - $112 Million	857,741 Added 117.99%	1,584,704 $204 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $16.3 Million - $19.3 Million	-156,673 Reduced 17.73%	726,963 $84.5 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $17.9 Million - $25.8 Million	210,075 Added 31.19%	883,636 $100 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $11 Million - $13.6 Million	143,904 Added 27.17%	673,561 $54.3 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $24 Million - $46.8 Million	352,367 Added 198.75%	529,657 $39.5 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $3.71 Million - $5.14 Million	39,461 Added 28.63%	177,290 $90.7 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $1.57 Million - $1.96 Million	-12,055 Reduced 8.04%	137,829 $74 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $2.93 Million - $3.94 Million	-27,488 Reduced 15.5%	149,884 $82 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $14.4 Million - $19.1 Million	177,372 New	177,372 $75.7 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Dexcom Inc Transaction History